These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 6083906

  • 1. Types of AT III abnormalities and their significance in hypercoagulability.
    Nagy I, Losonczy H.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):421-5. PubMed ID: 6083906
    [No Abstract] [Full Text] [Related]

  • 2. Clinical relevance of antithrombin III.
    Bick RL.
    Semin Thromb Hemost; 1982 Oct; 8(4):276-87. PubMed ID: 6758119
    [Abstract] [Full Text] [Related]

  • 3. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
    von Blohn G, Reiter B, Hellstern P, Wenzel E, Köhler M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Oct; 111(4):426-38. PubMed ID: 6083907
    [Abstract] [Full Text] [Related]

  • 4. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T, Jespersen J.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Oct; 111(4):407-15. PubMed ID: 6083904
    [Abstract] [Full Text] [Related]

  • 5. [Thromboembolism. The clinical significance of antithrombin III].
    Schramm W.
    Internist (Berl); 1984 Feb; 25(2):88-92. PubMed ID: 6368458
    [No Abstract] [Full Text] [Related]

  • 6. [A new antithrombin III variant: antithrombin III Budapest 2].
    Petö I, Blaskó G, Samu A, Sas G.
    Orv Hetil; 1988 Jan 03; 129(1):11-3. PubMed ID: 3281086
    [No Abstract] [Full Text] [Related]

  • 7. [Antithrombin III deficiency and tendency to thrombosis (author's transl)].
    Lechner K, Thaler E, Niessner H, Nowotny C, Partsch H.
    Wien Klin Wochenschr; 1977 Apr 01; 89(7):215-22. PubMed ID: 857429
    [Abstract] [Full Text] [Related]

  • 8. [Antithrombin III in various conditions in internal medicine].
    Malý J, Pecka M, Pidrman V, Zadák Z, Gregor J, Jebavý L, Bláha M, Siroký O.
    Vnitr Lek; 1997 Oct 01; 43(10):645-8. PubMed ID: 9601877
    [Abstract] [Full Text] [Related]

  • 9. Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S.
    Humphries JE.
    Semin Hematol; 1995 Oct 01; 32(4 Suppl 2):8-16; discussion 17-8. PubMed ID: 8821205
    [No Abstract] [Full Text] [Related]

  • 10. Antithrombin III. Comparison of functional and immunologic assays.
    Petersen C, Kelly R, Minard B, Cawley LP.
    Am J Clin Pathol; 1978 May 01; 69(5):500-4. PubMed ID: 77634
    [No Abstract] [Full Text] [Related]

  • 11. The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism.
    Vikydal R, Korninger C, Kyrle PA, Niessner H, Pabinger I, Thaler E, Lechner K.
    Thromb Haemost; 1985 Dec 17; 54(4):744-5. PubMed ID: 4089808
    [Abstract] [Full Text] [Related]

  • 12. [Antithrombin III and heparin].
    Zhu KC.
    Zhonghua Fu Chan Ke Za Zhi; 1988 May 17; 23(3):177-9. PubMed ID: 3058418
    [No Abstract] [Full Text] [Related]

  • 13. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2.
    Sacher R.
    Semin Hematol; 1995 Oct 17; 32(4 Suppl 2):67-71. PubMed ID: 8821213
    [No Abstract] [Full Text] [Related]

  • 14. [Plasma antithrombin III activity in patients with pulmonary thromboembolism].
    Vertun B, Filipecki S, Szczepański M, Wawrzyńska L, Rózycka J.
    Pol Tyg Lek; 1995 Oct 17; 47(34-35):726-9. PubMed ID: 1488357
    [Abstract] [Full Text] [Related]

  • 15. [Thrombophilic states in late gestosis].
    Niedner W, Peterseim H, Hofmann KD, Hindersin P.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Oct 17; 111(4):528-34. PubMed ID: 6083923
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR, Weenink AH, Treffers PE, Kahlé LH, Otten HA, ten Cate JW.
    Scand J Haematol; 1980 Jul 17; 25(1):81-6. PubMed ID: 7444377
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Substitution of antithrombin III.
    Breddin HK, Kirchmaier CM.
    Wien Klin Wochenschr; 1984 Dec 21; 96(24):875-9. PubMed ID: 6528616
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.